In CRC, it has not been studied whether the oncogenic role of TRIM59 is through direct degradation of p53; only in stomach cancer does the literature report a direct TRIM59-p53 interaction and subsequent p53 degradation [170]. The gene discussed is TP53; the disease is gastric cancer.